Business Description
Evolent Health Inc
NAICS : 621999
SIC : 8099
800 N. Glebe Road, Suite 500, Arlington, VA, USA, 22203
Description
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. The company's reportable segments are Service segment which includes value-based care services, specialty care management services and comprehensive health plan administration services. and True Health segment consists of a commercial health plan it operates in New Mexico that focuses on small and large businesses. It generates a majority of its revenue from the Service segment.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.56 | |||||
Equity-to-Asset | 0.47 | |||||
Debt-to-Equity | 0.57 | |||||
Debt-to-EBITDA | 5.93 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.9 | |||||
Beneish M-Score | -3.18 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 9.2 | |||||
3-Year EPS without NRI Growth Rate | 19.7 | |||||
3-Year Book Growth Rate | -18.7 | |||||
Future 3-5Y Total Revenue Growth Rate Industry Rank | 20.83 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 21.91 | |||||
9-Day RSI | 37.34 | |||||
14-Day RSI | 45.76 | |||||
6-1 Month Momentum % | 30.86 | |||||
12-1 Month Momentum % | 37.65 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.23 | |||||
Quick Ratio | 1.23 | |||||
Cash Ratio | 0.56 | |||||
Days Sales Outstanding | 56.78 | |||||
Days Payable | 30.62 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.1 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 26.73 | |||||
Operating Margin % | -0.5 | |||||
Net Margin % | -2.63 | |||||
ROE % | -4.56 | |||||
ROA % | -2.17 | |||||
ROIC % | -0.53 | |||||
ROC (Joel Greenblatt) % | -1.08 | |||||
ROCE % | -0.16 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 63.44 | |||||
PS Ratio | 2.85 | |||||
PB Ratio | 5.17 | |||||
Price-to-Free-Cash-Flow | 81.82 | |||||
Price-to-Operating-Cash-Flow | 44.94 | |||||
EV-to-EBIT | -2316.2 | |||||
EV-to-Forward-EBIT | 45.79 | |||||
EV-to-EBITDA | 57.62 | |||||
EV-to-Revenue | 3.09 | |||||
EV-to-Forward-Revenue | 2.38 | |||||
EV-to-FCF | 88.22 | |||||
Earnings Yield (Greenblatt) % | -0.04 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NYSE:EVH
Executives
EMBED
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 1,087.825 | ||
EPS (TTM) ($) | -0.32 | ||
Beta | 2.2 | ||
Volatility % | 46.25 | ||
14-Day RSI | 45.76 | ||
14-Day ATR ($) | 1.725563 | ||
20-Day SMA ($) | 34.5075 | ||
12-1 Month Momentum % | 37.65 | ||
52-Week Range ($) | 21.36 - 39 | ||
Shares Outstanding (Mil) | 91.67 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Evolent Health Inc Filings
Document | Form | Filing Date | ||
---|---|---|---|---|
No Filing Data |